MILTA ESCOTO: Open Payments
NPI 1407638083 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,787 in 95 payments from 15 companies in 2025. Trend: 2023 $18 · 2024 $1,630 · 2025 $1,787
Food & beverage: $1,787
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 28 | $309 |
| Averitas Pharma Inc. | 8 | $291 |
| JAZZ PHARMACEUTICALS INC. | 7 | $278 |
| Collegium Pharmaceutical, Inc. | 19 | $212 |
| ABBVIE INC. | 6 | $141 |
| VERTEX PHARMACEUTICALS INCORPORATED | 6 | $135 |
| SK Life Science, Inc. | 5 | $96 |
| Lundbeck LLC | 4 | $84 |
| UCB, Inc. | 2 | $56 |
| Alnylam Pharmaceuticals Inc. | 3 | $48 |
Products named: RELISTOR, QUTENZA, XYWAV, Belbuca, JOURNAVX, BOTOX, VYEPTI, Fintepla.
Industry payments across NY — which companies pay providers there.
